SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-06-045733
Filing Date
2006-11-07
Accepted
2006-11-07 17:13:16
Documents
1
Period of Report
2006-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v056705_8ka.htm 8-K/A 1932435
  Complete submission text file 0001144204-06-045733.txt   1934324
Mailing Address 1220 GLENMORE DRIVE APOPKA FL 32712
Business Address 1220 GLENMORE DRIVE APOPKA FL 32712 407-880-2213
SHEFFIELD PHARMACEUTICALS INC (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12584 | Film No.: 061194745
SIC: 6770 Blank Checks